CBIO - 3.39 Pre-market now at 3.80/3.90 BZ: Catalyst Biosciences Reports Factor IX Data: 'CB 2679d/ISU304 is approximately 22 times more potent than current hemophilia B therapy' Catalyst Biosciences Announces Positive Factor IX Clinical Data http://stockcharts.com/c-sc/sc?s=CBIO&p=D&b=5&g=0&i=t65040954511&r=1504699491520 http://stockcharts.com/c-sc/sc?s=CBIO&p=W&b=5&g=0&i=t56452508104&r=1504699474495